I. M. Holdaway and C. Rajasoorya, Epidemiology of acromegaly, Pituitary, vol.2, issue.1, pp.29-41, 1999.
DOI : 10.1023/A:1009965803750

N. Sanno, A. Teramoto, and R. Y. Osamura, Pathology of pituitary tumors, Neurosurgery Clinics of North America, vol.14, issue.1, pp.25-39, 2003.
DOI : 10.1016/S1042-3680(02)00035-9

P. Chanson and S. Salenave, Acromegaly, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.17, 2008.
DOI : 10.1186/1750-1172-3-17
URL : https://hal.archives-ouvertes.fr/hal-00017712

S. Melmed, A. Colao, and A. Barkan, Guidelines for Acromegaly Management: An Update, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.5, pp.1509-1517, 2009.
DOI : 10.1210/jc.2008-2421

I. M. Holdaway, M. J. Bolland, and G. D. Gamble, A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly, European Journal of Endocrinology, vol.159, issue.2, pp.89-95, 2008.
DOI : 10.1530/EJE-08-0267

R. Kauppinen-makelin, T. Sane, and A. Reunanen, A Nationwide Survey of Mortality in Acromegaly, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.7, pp.4081-4086, 2005.
DOI : 10.1210/jc.2004-1381

A. Giustina, A. Barkan, and F. F. Casanueva, Criteria for Cure of Acromegaly: A Consensus Statement??, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.2, pp.526-529, 2000.
DOI : 10.1210/jc.85.2.526

A. Giustina, P. Chanson, and M. D. Bronstein, A Consensus on Criteria for Cure of Acromegaly, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.7, pp.141-3148, 2010.
DOI : 10.1210/jc.2009-2670

S. Melmed, F. Casanueva, and F. Cavagnini, Consensus statement: medical management of acromegaly, European Journal of Endocrinology, vol.153, issue.6, pp.737-740, 2005.
DOI : 10.1530/eje.1.02036
URL : https://hal.archives-ouvertes.fr/hal-00017712

A. Giustina, M. D. Bronstein, and F. F. Casanueva, Current management practices for acromegaly: an international survey, Pituitary, vol.10, issue.2, pp.125-133, 2011.
DOI : 10.1007/s11102-007-0037-7

P. U. Freda, Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?, Clinical Endocrinology, vol.80, issue.Suppl 1, pp.166-170, 2009.
DOI : 10.1111/j.1365-2265.2009.03556.x

P. J. Trainer, J. Barth, and C. Sturgeon, Consensus statement on the standardisation of GH assays, European Journal of Endocrinology, vol.155, issue.1, pp.1-2, 2006.
DOI : 10.1530/eje.1.02186

C. Beauregard, U. Truong, and J. Hardy, Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly, Clinical Endocrinology, vol.39, issue.1, pp.86-91, 2003.
DOI : 10.1016/S0140-6736(00)04006-X

N. R. Biermasz, H. Van-dulken, and F. Roelfsema, Ten-Year Follow-Up Results of Transsphenoidal Microsurgery in Acromegaly, The Journal of Clinical Endocrinology & Metabolism, vol.85, issue.12, pp.4596-4602, 2000.
DOI : 10.1210/jcem.85.12.7042

B. 16-swearingen, F. G. Barker, and L. Katznelson, Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.10, pp.3419-3426, 1998.
DOI : 10.1210/jc.83.10.3419

N. R. Biermasz, F. W. Dekker, and A. M. Pereira, Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2789-2796, 2004.
DOI : 10.1210/jc.2003-032041

J. D. Carmichael, V. S. Bonert, and J. M. Mirocha, The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.2, pp.523-527, 2009.
DOI : 10.1210/jc.2008-1371

R. 19-fahlbusch, J. Honegger, and M. Buchfelder, Evidence supporting surgery as treatment of choice for acromegaly, The Journal of Endocrinology, vol.155, pp.53-55, 1997.

G. A. 20-kaltsas, A. M. Isidori, and D. Florakis, Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.4, pp.1645-1652, 2001.
DOI : 10.1210/jcem.86.4.7398

R. 21-trepp, C. Stettler, and M. Zwahlen, Treatment outcomes and mortality of 94 patients with acromegaly, Acta Neurochirurgica, vol.147, issue.3, pp.243-251, 2005.
DOI : 10.1007/s00701-004-0466-2

J. Jr, J. A. Starke, R. M. Elzoghby, and M. A. , Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome, Journal of Clinical Endocrinology and Metabolism, vol.96, pp.2732-2740, 2011.

C. P. Hofstetter, R. H. Mannaa, and L. Mubita, Endoscopic endonasal transsphenoidal surgery for growth hormone???secreting pituitary adenomas, Neurosurgical Focus, vol.29, issue.4, p.6, 2010.
DOI : 10.3171/2010.7.FOCUS10173

I. Shimon, Z. R. Cohen, and Z. Ram, Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients, Neurosurgery, vol.48, pp.1239-1243, 2001.

P. U. Freda, S. L. Wardlaw, and K. D. Post, Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly, Journal of Neurosurgery, vol.89, issue.3, pp.353-358, 1998.
DOI : 10.3171/jns.1998.89.3.0353

A. L. Espinosa-de-los-monteros, E. Sosa, and S. Cheng, Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status, Clinical Endocrinology, vol.21, issue.3, pp.245-249, 2006.
DOI : 10.1016/S1096-6374(03)00030-3

G. Minniti, M. L. Jaffrain-rea, and V. Esposito, Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature, Endocrine Related Cancer, vol.10, issue.4, pp.611-619, 2003.
DOI : 10.1677/erc.0.0100611

V. J. 28-parfitt, D. Flanagan, and P. Wood, Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1, Clinical Endocrinology, vol.307, issue.5, pp.647-652, 1998.
DOI : 10.1046/j.1365-2265.1998.00534.x

A. Abosch, J. B. Tyrrell, and K. R. Lamborn, Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results, The Journal of Clinical Endocrinology & Metabolism, vol.83, issue.10, pp.3411-3418, 1998.
DOI : 10.1210/jcem.83.10.5111

A. Bourdelot, J. Coste, and V. Hazebroucq, Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly, European Journal of Endocrinology, vol.150, issue.6, pp.763-771, 2004.
DOI : 10.1530/eje.0.1500763

J. 31-kreutzer, M. L. Vance, and M. B. Lopes, Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.9, pp.4072-4077, 2001.
DOI : 10.1210/jcem.86.9.7819

J. W. Tomlinson, N. Holden, and R. K. Hills, Association between premature mortality and hypopituitarism, The Lancet, vol.357, issue.9254, pp.425-431, 2001.
DOI : 10.1016/S0140-6736(00)04006-X

T. Florio, F. Barbieri, and R. Spaziante, Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study, Endocrine Related Cancer, vol.15, issue.2, pp.583-596, 2008.
DOI : 10.1677/ERC-07-0271
URL : https://hal.archives-ouvertes.fr/hal-00398613

S. 34-petersenn, J. Schopohl, and A. Barkan, Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.6, pp.2781-2789, 2010.
DOI : 10.1210/jc.2009-2272